Merck KGaA Asset Resilience Ratio

Latest as of March 2026: 1.94%

Merck KGaA asset resilience ratio. Merck KGaA (MRK) has an Asset Resilience Ratio of 1.94% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read MRK liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

€1.03 Billion

≈ $1.21 Billion USD Cash + Short-term Investments

Total Assets

€53.07 Billion

≈ $62.04 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Merck KGaA (2005–2025)

Asset resilience ratio of Merck KGaA from 2005 to 2025. This chart shows how Merck KGaA's Asset Resilience Ratio has changed over time. See how much free cash does Merck KGaA generate to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Merck KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MRK total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.03 Billion	1.94%
Total Liquid Assets	€1.03 Billion	1.94%

Asset Resilience Insights

Limited Liquidity: Merck KGaA maintains only 1.94% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Merck KGaA Industry Peers by Asset Resilience Ratio

Compare Merck KGaA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.09%
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	Drug Manufacturers - Specialty & Generic	14.54%

Merck KGaA Asset Resilience Ratio by Year (2005–2025)

Merck KGaA asset resilience ratio by year from 2005 to 2025. The table below shows the annual Asset Resilience Ratio data for Merck KGaA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.15%	€597.00 Million ≈ $697.96 Million	€52.10 Billion ≈ $60.91 Billion	+0.06pp
2024-12-31	1.08%	€558.00 Million ≈ $652.36 Million	€51.57 Billion ≈ $60.29 Billion	+0.61pp
2023-12-31	0.48%	€231.00 Million ≈ $270.06 Million	€48.49 Billion ≈ $56.70 Billion	-0.03pp
2022-12-31	0.50%	€244.00 Million ≈ $285.26 Million	€48.53 Billion ≈ $56.73 Billion	+0.26pp
2021-12-31	0.25%	€112.00 Million ≈ $130.94 Million	€45.36 Billion ≈ $53.03 Billion	+0.18pp
2020-12-31	0.07%	€29.00 Million ≈ $33.90 Million	€41.80 Billion ≈ $48.86 Billion	+0.00pp
2019-12-31	0.07%	€29.00 Million ≈ $33.90 Million	€43.81 Billion ≈ $51.22 Billion	+0.04pp
2018-12-31	0.02%	€8.00 Million ≈ $9.35 Million	€36.89 Billion ≈ $43.13 Billion	-0.08pp
2017-12-31	0.10%	€35.00 Million ≈ $40.92 Million	€35.62 Billion ≈ $41.64 Billion	-0.01pp
2016-12-31	0.11%	€43.00 Million ≈ $50.27 Million	€38.25 Billion ≈ $44.72 Billion	-0.39pp
2015-12-31	0.50%	€191.40 Million ≈ $223.77 Million	€38.01 Billion ≈ $44.43 Billion	-7.79pp
2014-12-31	8.29%	€2.16 Billion ≈ $2.52 Billion	€26.01 Billion ≈ $30.41 Billion	-3.07pp
2013-12-31	11.36%	€2.37 Billion ≈ $2.77 Billion	€20.82 Billion ≈ $24.34 Billion	+4.06pp
2012-12-31	7.30%	€1.58 Billion ≈ $1.85 Billion	€21.64 Billion ≈ $25.30 Billion	+2.25pp
2011-12-31	5.05%	€1.12 Billion ≈ $1.31 Billion	€22.12 Billion ≈ $25.86 Billion	+4.80pp
2010-12-31	0.25%	€55.60 Million ≈ $65.00 Million	€22.39 Billion ≈ $26.17 Billion	-8.75pp
2009-12-31	8.99%	€1.50 Billion ≈ $1.76 Billion	€16.71 Billion ≈ $19.54 Billion	+7.86pp
2008-12-31	1.13%	€176.80 Million ≈ $206.70 Million	€15.64 Billion ≈ $18.29 Billion	-2.66pp
2007-12-31	3.79%	€565.30 Million ≈ $660.90 Million	€14.92 Billion ≈ $17.45 Billion	+2.15pp
2006-12-31	1.64%	€133.10 Million ≈ $155.61 Million	€8.10 Billion ≈ $9.47 Billion	-0.48pp
2005-12-31	2.12%	€154.20 Million ≈ $180.28 Million	€7.28 Billion ≈ $8.51 Billion	--

pp = percentage points

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$22.71 Billion

€19.43 Billion EUR

Market Cap Rank

#1135 Global

#260 in Germany

Share Price

€150.30

Change (1 day)

+2.91%

52-Week Range

€102.80 - €150.30

All Time High

€220.61